-
In August 2026, Merit Medical Systems announced that Sheri Lewis would join as Executive Vice President of Global Operations, bringing three decades of global manufacturing and supply chain experience from SkinHealth Systems, Avantor, Medtronic, and Honeywell, while long-time operations leader Mr. Peterson shifted to a Senior Advisor role through March 2027 to support continuity.
-
This leadership transition highlights Merit’s focus on strengthening global operations and supply chain resilience at a time when execution and efficiency are central to its growth ambitions.
-
Next, we’ll look at how Lewis’s extensive global operations experience could influence Merit’s investment narrative and long-term growth drivers.
Find 50 companies with promising cash flow potential yet trading below their fair value.
Merit Medical Systems Investment Narrative Recap
To own Merit Medical Systems, you need to believe it can keep turning a focused vascular and oncology device portfolio into steady revenue and earnings growth while managing reimbursement, pricing, and product-quality risks. The appointment of Sheri Lewis as Executive Vice President of Global Operations looks incremental rather than transformational for the near term, but it may support execution on cost control and supply chain resilience, which are central to both the WRAPSODY reimbursement opportunity and the risk of margin pressure from tariffs and higher operating expenses.
One related recent development is Merit’s raised 2026 revenue guidance to US$1.631 billion to US$1.643 billion after solid first half results, which underscores how important consistent operational execution has become to the story. Against that backdrop, bringing in a seasoned global operations leader and retaining the former COO as Senior Advisor could help the company handle product recalls, logistics complexity, and potential tariff volatility that might otherwise chip away at the higher revenue and earnings targets that analysts are using in their models.
Yet, beneath the headline of stronger operations, investors should be aware that the real swing factor may be how Merit handles potential setbacks in…
Read the full narrative on Merit Medical Systems (it’s free!)
Merit Medical Systems’ narrative projects $1.9 billion revenue and $226.4 million earnings by 2029. This requires 6.3% yearly revenue growth and about a $80.8 million earnings increase from $145.6 million today.
Uncover how Merit Medical Systems’ forecasts yield a $100.27 fair value, a 11% upside to its current price.
